Health ❯ Healthcare ❯ Clinical Trials

Drug Safety

Adverse Events Adverse Effects Effectiveness Studies Pharmaceuticals Patient Quality of Life Biotechnology Medication Risks Venous Thrombosis Toxicity Assessment Icovamenib Side Effects Foundayo

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Company-presented ATTD findings will guide dosing decisions for follow-on Phase II trials targeting defined patient groups.

Apixaban Cuts Bleeding Versus Rivaroxaban in Venous Thrombosis, NEJM Head-to-Head Trial Finds

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models